The Netherlands
CleanNA's proprietary magnetic bead technology has garnered attention for its ability to deliver high-quality nucleic acid purification, making it highly effective for cleanup of PCR and sequencing products for both Sanger Sequencing and Next Generation Sequencing. The startup's magnetic bead-based solutions are designed for DNA and RNA isolation from diverse sample sources, including Whole Blood, FFPE, and Plant tissue.
One of CleanNA's key strengths lies in its versatility, as its protocols are tailored for high-throughput nucleic acid purification and can easily be adapted on commercially available liquid handling instruments. Furthermore, the company's proprietary chemistries have broad applications in various markets, including sequencing core facilities in academic institutions, diagnostic centers, and sequencing services providers across Europe and worldwide.
While specific details about the startup's last investment are currently unavailable, CleanNA is undoubtedly a compelling prospect for potential investors seeking opportunities in cutting-edge life science technologies.
